FDA Adverse Event Malfunction Summary report: N

UNICEL® DXC 600 SYNCHRON® SYSTEM

MDR report key: 2565097 · Received May 8, 2012

Report

Report Number
2050012-2012-01096
Event Type
Malfunction
Date Received
May 8, 2012
Date of Event
April 12, 2012
Report Date
April 12, 2012
Manufacturer
BECKMAN COULTER, INC.
Product Code
JJE
PMA / PMN Number
K042291
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE FIELD SERVICE ENGINEER (FSE) DISCOVERED THE CARTRIDGE CHEMISTRY (CC) REAGENT SYRINGE HAD A SIGNIFICANT AMOUNT OF AIR IN IT. THE FSE REPLACED THE PLUNGER AND PRIMED THE SYRINGE. THERE WAS NO LONGER AIR IN THE SYRINGE. THE FSE REPLACED THE CC SAMPLE PROBE, AS IT MAY HAVE HAD A CLOT IN IT. BLOOD UREA NITROGEN (BUN) WAS ABLE TO BE CALIBRATED AND QUALITY CONTROL (QC) WAS WITHIN RANGE. THE UNIT CONFORMED TO THE MANUFACTURER'S PUBLISHED PERFORMANCE SPECIFICATIONS.

Description of Event or Problem · 1

THE CUSTOMER REPORTED OBTAINING SEVERAL OUT OF ANALYTICAL RANGE AND SUPPRESSED OIR HI (OUT OF INSTRUMENT RANGE HIGH) AND OIR LO (OUT OF INSTRUMENT RANGE LOW) RESULTS FOR MULTIPLE PATIENTS, FOR CARTRIDGE CHEMISTRY (CC) INVOLVING UNICEL DXC 600 SYNCHRON SYSTEM. BECKMAN COULTER CUSTOMER TECHNICAL SUPPORT (CTS) ADVISED THE CUSTOMER TO USE PROPER PERSONAL PROTECTIVE EQUIPMENT (PPE) PRIOR TO TROUBLESHOOTING. THE CUSTOMER INSPECTED THE CARTRIDGE CHEMISTRY (CC) SAMPLE AND CC REAGENT SYRINGES AND INDICATED THE CC REAGENT SYRINGE WAS EASILY LOOSENED AND CONTAINED A LARGE AIR BUBBLE. THE ERRONEOUS RESULTS WERE NOT RELEASED OUT OF THE LABORATORY. THERE WAS NO REPORT OF PATIENT INJURY OR CHANGE IN PATIENT TREATMENT ASSOCIATED WITH THIS INCIDENT. THE FIELD SERVICE ENGINEER (FSE) ASSESSED THE UNIT AT THE FACILITY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL® DXC 600 SYNCHRON® SYSTEM ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE JJE BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1